The renoprotective effects of tadalafil on ischemia-reperfusion injury during partial nephrectomy in an animal model.

BACKGROUND

Although 25 min is the reported safe partial nephrectomy time for warm ischemia, acute kidney injury occurs even with arterial ligation within 25 min, causing serious complications in patients with chronic renal disease. Various drugs have been studied but evidence of their effectiveness and safety is insufficient. This study investigated the renoprotective function of tadalafil.

METHODS

A rat model of partial nephrectomy was treated orally with tadalafil for 14 days before ischemic-reperfusion (IR) injury. Blood and kidney samples were collected for biochemical and molecular analyses 24 h after IR injury. The levels of serum blood urea nitrogen, creatinine, and urine kidney injury molecule-1 were analyzed, while kidney tissues were used for qPCR and histological analysis.

RESULTS

Although effects on blood urea nitrogen and creatine levels were not observed, tadalafil preserved renal function by suppressing the decrease of viable glomeruli, indicating it protected kidneys from IR injury-induced glomeruli loss. Tadalafil effectively reduced the expression of the oxidative stress markers, inducible NOS, endothelial NOS, and myeloperoxidase, and significantly suppressed the expression of inflammation-related genes like TNF-α, IL-1β, IL-6, CD4, and CD8.

CONCLUSIONS

Tadalafil inhibits oxidative stress and inflammation, and protects from glomeruli loss during ischemic-reperfusion damage in a rat model of partial nephrectomy.

CLINICAL TRIAL NUMBER

Not applicable.